Indefinite Delivery Contract SPE2DX17D1056

This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs. The single-award IDC, valued at up to $4,999,999.00, runs through December 2025 and serves as the primary vehicle for the company to deliver essential medical commodities to DLA facilities worldwide. This includes specialty medications, brand-name and generic drugs, over-the-counter medications, syringes, vials, test kits, and other critical care materials across various therapeutic areas. The contract was awarded through full and open competition without any set-aside designations.

The task orders provided demonstrate the delivery of specific pharmaceutical products to support the DLA Troop Support Medical facilities located in Chesterbrook, Pennsylvania. These firm-fixed-price delivery orders, ranging from approximately $690 to $1,586, cover a variety of prescription medications and medical supplies. The scope of this IDC aligns with Amerisourcebergen's role as a major pharmaceutical distributor and healthcare solutions provider, leveraging its extensive supply chain network to efficiently fulfill government contracts for essential medical commodities to the Department of Defense and other federal agencies.